in addition , we have demonstrated how the monitoring of more than one immune reactant , characterization of cic size and composition , and evaluation of resulting reequilibrium caused by in vitro addition of antigen or antibody , could allow for an improved assessment of humoral immunity and its related pathogenetic effects in cancer patients .
C0003320
antigen
C0020967
humoral immunity